Lancet Capital, 45 Rockefeller Plaza Ste 2008, New York, New York
Summary
The estimated net worth of George L. Sing is at least $27.9 M dollars as of May 6, 2024. George L. Sing is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $27.9 M.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.